Answers are grounded in this paper and cite their sources.
The ability of a homogeneous IgG2a monoclonal antibody against Thy 1.1 antigen to selectively bind to Thy 1-containing tissues in congenic AKR mice was tested as a function of time. The rapid clearance from blood of [125I]-labeled 19-F12(M) antibody from AKR/J (Thy 1.1) mice, compared to that of AKR/Cu (Thy 1.2) mice, was consistent with the specificity of the antibody and its homing into target tissues. The selective localization of this antibody into lymphatic tissues was time dependent. At optimal times (20 hr post-injection) the lymph nodes of AKR/J mice contained 9-fold more antibody than the lymph nodes of AKR/Cu mice. Localization of the F(ab′)2 fragment of 19-F12(M) antibody into lymphatic tissues was even more striking. Clearance of the F(ab′)2 from blood was extremely rapid, and at 16 hr after injection, the lymph nodes of AKR/J mice contained 144-fold more F(ab’)2 than did the lymph nodes of AKR/Cu mice. When localization within specific organs was determined relative to nonimmune IgG2a the F(ab′)2 concentrated into lymph nodes and spleen of AKR/J mice by factors in excess of 475 and 250, respectively. In contrast, neither intact 19-F12(M) antibody or its F(ab′)2 fragment were concentrated in the lymphatic tissues of AKR/Cu mice. These studies demonstrate that monoclonal antibodies against Thy 1.1 antigen possess sufficient specificity, homogeneity, and avidity to selectively localize in appropriate target tissues in vivo.
No takes yet. Share an insight, caveat, or question.
Houston et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: